廣告
香港股市 已收市
  • 恒指

    18,444.11
    +41.11 (+0.22%)
     
  • 國指

    6,554.32
    +22.33 (+0.34%)
     
  • 上證綜指

    3,091.20
    +4.39 (+0.14%)
     
  • 道指

    38,571.03
    -115.27 (-0.30%)
     
  • 標普 500

    5,283.40
    +5.89 (+0.11%)
     
  • 納指

    16,828.67
    +93.67 (+0.56%)
     
  • Vix指數

    13.77
    +0.66 (+5.04%)
     
  • 富時100

    8,216.64
    -46.11 (-0.56%)
     
  • 紐約期油

    73.19
    -1.03 (-1.39%)
     
  • 金價

    2,353.90
    -15.40 (-0.65%)
     
  • 美元

    7.8137
    -0.0058 (-0.07%)
     
  • 人民幣

    0.9265
    +0.0009 (+0.10%)
     
  • 日圓

    0.0501
    +0.0002 (+0.46%)
     
  • 歐元

    8.5007
    -0.0226 (-0.26%)
     
  • Bitcoin

    69,039.86
    -186.76 (-0.27%)
     
  • CMC Crypto 200

    1,447.10
    -0.05 (-0.00%)
     

Celanese (CE) Reports Q1 Earnings: What Key Metrics Have to Say

For the quarter ended March 2024, Celanese (CE) reported revenue of $2.61 billion, down 8.5% over the same period last year. EPS came in at $2.08, compared to $2.01 in the year-ago quarter.

The reported revenue represents a surprise of -5.01% over the Zacks Consensus Estimate of $2.75 billion. With the consensus EPS estimate being $1.91, the EPS surprise was +8.90%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

廣告

Here is how Celanese performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net Sales- Acetyl Chain: $1.26 billion versus $1.19 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +0.9% change.

  • Net Sales- Inter segment eliminations: -$28 million versus -$23.69 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +3.7% change.

  • Net Sales- Engineered Materials: $1.38 billion compared to the $1.56 billion average estimate based on five analysts. The reported number represents a change of -15.5% year over year.

  • Operating EBITDA- Acetyl Chain: $353 million versus the five-analyst average estimate of $337.65 million.

  • Operating EBITDA- Engineered Materials: $303 million versus $304.42 million estimated by five analysts on average.

  • Operating EBITDA- Other Activities: -$73 million versus -$74.95 million estimated by four analysts on average.

View all Key Company Metrics for Celanese here>>>

Shares of Celanese have returned -2.1% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Celanese Corporation (CE) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research